Mosquito-borne diseases, including dengue, Zika, and yellow fever, continue to pose a significant global health threat, ...

Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024 Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ...

The CBSE Class 10 exams will take place between February 17 and March 10, and the Class 12 exams will be conducted from ...

Total net revenue increased 20.5% to $17.6 million for third quarter of 2025 compared to the third quarter of 2024 Fortress subsidiary Checkpoint ...

Q3 2025 Earnings Call Transcript November 13, 2025 Protalix BioTherapeutics, Inc. misses on earnings expectations. Reported ...

Presented new data at the Society of Immunotherapy for Cancer (SITC) annual meeting on CLD-401 protection from immune clearance after systemic administration; data also demonstrates that the platform ...

Medicxi, a leading European life sciences venture capital firm, today announced the closing of Medicxi V, a €500 million fund dedicated ...